TCTP is essential for β-cell proliferation and mass expansion during development and β-cell adaptation in response to insulin resistance

Endocrinology

Volumn 155, Issue 2, 2014, Pages 392-404

  Tsai, Ming Jen ^a,b   Yang Yen, Hsin Fang ^c   Chiang, Ming Ko ^d   Wang, Mei Jen ^b   Wu, Shiou Shian ^a   Chen, Sung Ho ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b Department of Neurosurgery   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE 2; FORKHEAD TRANSCRIPTION FACTOR; INSULIN; PROTEIN P53; S6 KINASE; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELL GROWTH; CELL PROLIFERATION; CELLULAR PARAMETERS; CELLULAR SECRETION; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; EVOLUTIONARY ADAPTATION; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MALE; MASS; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CELL PROLIFERATION; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; TUMOR MARKERS, BIOLOGICAL;

EID: 84893204701     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1663     Document Type: Article

References (53)

1. Ackermann AM, Gannon M. Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007;38: 193-206.
2. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol. 2000;24: 297-302.
3. Accili D. A kinase in the life of the β cell. J Clin Invest. 2001;108: 1575-1576.
4. Assmann A, Hinault C, Kulkarni RN. Growth factor control of pancreatic islet regeneration and function. Pediatr Diabetes. 2009; 10: 14-32.
5. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes. 1995;44: 249-256.
6. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429: 41-46.
7. Georgia S, Bhushan A. β Cell replication is the primary mechanism for maintaining postnatal β cell mass. J Clin Invest. 2004;114: 963-968.
8. Bommer UA, Thiele BJ. The translationally controlled tumour protein (TCTP). Int J Biochem Cell Biol. 2004;36: 379-385.
9. Thaw P, Baxter NJ, Hounslow AM, Price C, Waltho JP, Craven CJ. Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones. Nat Struct Biol. 2001;8: 701-704.
10. Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer UA. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci. 1999;112(pt 8): 1257-1271.
11. YarmFR. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol. 2002;22: 6209-6221.
12. Cans C, Passer BJ, Shalak V, et al. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc Natl Acad SciUSA. 2003; 100: 13892-13897.
13. Yang T, Buchan HL, Townsend KJ, Craig RW. MCL-1, a member of the BLC-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J Cell Physiol. 1996;166: 523-536.
14. Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem. 2001;276: 47542-47549.
15. Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol. 2005;25: 3117-3126.
16. Susini L, Besse S, Duflaut D, et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008;15: 1211-1220.
17. Kim M, Jung J, Lee K. Roles of ERK, PI3 kinase, and PLC-γ pathways induced by overexpression of translationally controlled tumor protein in HeLa cells. Arch Biochem Biophys. 2009;485: 82-87.
18. Jung J, Kim HY, Kim M, Sohn K, Kim M, Lee K. Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src. Oncogene. 2011;30: 2264-2274.
19. Hsu YC, Chern JJ, Cai Y, Liu M, Choi KW. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature. 2007;445: 785-788.
20. Dong X, Yang B, Li Y, Zhong C, Ding J. Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein. J Biol Chem. 2009;284: 23754-23764.
21. Kim DK, Nam BY, Li JJ, et al. Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes. Diabetologia. 2012;55: 1205-1217.
22. Rho SB, Lee JH, Park MS, et al. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett. 2011; 585: 29-35.
23. Amson R, Pece S, Lespagnol A, et al. Reciprocal repression between P53 and TCTP. Nat Med. 2012;18: 91-99.
24. Chen SH, Wu PS, Chou CH, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell. 2007;18: 2525-2532.
25. Thiele H, Berger M, Skalweit A, Thiele BJ. Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumour protein (TCTP). Eur J Biochem. 2000; 267: 5473-5481.
26. Diraison F, Hayward K, Sanders KL, et al. Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic β cells. Diabetologia. 2011;54: 368-379.
27. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β celldoi specific gene knock-outs using Cre recombinase. J Biol Chem. 1999; 274: 305-315.
28. Lee JY, RistowM,Lin X, White MF, MagnusonMA,Hennighausen L. RIP-Cre revisited, evidence for impairments of pancreatic β-cell function. J Biol Chem. 2006;281: 2649-2653.
29. Pomplun D, Florian S, Schulz T, Pfeiffer AF, Ristow M. Alterations of pancreatic β-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2. Horm Metab Res. 2007;39: 336-340.
30. Ackermann Misfeldt A, Costa RH, Gannon M. β-Cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes. 2008;57: 3069-3077.
31. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation. 1985;40: 437-438.
32. Gonzalez A, Merino B, Marroquí L, et al. Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells. Endocrinology. 2013;154: 3515-3524.
33. Glauser DA, Schlegel W. The emerging role of FOXO transcription factors in pancreatic β cells. J Endocrinol. 2007;193: 195-207.
34. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ. CDK2-dependent phosphorylation of FOXO1 as an apoptotic response toDNAdamage. Science. 2006;314: 294-297.
35. Kitamura T. The role ofFOXO1inβ-cell failure and type 2 diabetes mellitus. Nat Rev Endocrinol. 2013;9: 615-623.
36. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18: 1926-1945.
37. Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA. Rictor/ mTORC2 is essential for maintaining a balance between β-cell proliferation and cell size. Diabetes. 2011;60: 827-837.
38. Kon N, Zhong J, Qiang L, Accili D, Gu W. Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. J Biol Chem. 2012;287: 5102-5111.
39. Hinault C, Kawamori D, Liew CW, et al. δ40 isoform of p53 controls β-cell proliferation and glucose homeostasis in mice. Diabetes. 2011;60: 1210-1222.
40. Georgia S, Hinault C, Kawamori D, et al. Cyclin D2 is essential for the compensatory β-cell hyperplastic response to insulin resistance in rodents. Diabetes. 2010;59: 987-996.
41. Schmidt I, Fähling M, Nafz B, Skalweit A, Thiele BJ. Induction of translationally controlled tumor protein (TCTP) by transcriptional and post-transcriptional mechanisms. FEBS J. 2007;274: 5416-5424.
42. Bommer UA, Heng C, Perrin A, et al. Roles of the translationally controlled tumour protein (TCTP) and the double-stranded RNAdependent protein kinase, PKR, in cellular stress responses. Oncogene. 2010;29: 763-773.
43. Tuttle RL, Gill NS, Pugh W, et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/ PKBα. Nat Med. 2001;7: 1133-1137.
44. Elghazi L, Balcazar N, Blandino-Rosano M, et al. Decreased IRS signaling impairs β-cell cycle progression and survival in transgenic mice overexpressing S6K in β-cells. Diabetes. 2010;59: 2390-2399.
45. Velazquez-Garcia S, Valle S, Rosa TC, et al. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and inducesβ-cell expansion viamTORactivation. Diabetes. 2011; 60: 2546-2559.
46. Treins C, Alliouachene S, Hassouna R, Xie Y, Birnbaum MJ, Pende M. The combined deletion of S6K1 and Akt2 deteriorates glycemic control in a high-fat diet. Mol Cell Biol. 2012;32: 4001-4011.
47. Pende M, Kozma SC, Jaquet M, et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature. 2000;408: 994-997.
48. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest. 2002;110: 1839-1847.
49. Kikuchi O, Kobayashi M, Amano K, et al. FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization. PLoS One. 2012;7:e32249.
50. Marine JC, Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ. 2010;17: 93-102.
51. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell. 2005;121: 1071-1083.
52. Ogawara Y, Kishishita S, Obata T, et al. Akt enhances Mdm2- mediated ubiquitination and degradation of p53. J BiolChem. 2002; 277: 21843-21850.
53. Tsubouchi S, Kano E, Suzuki H. Demonstration of expanding cell populations in mouse pancreatic acini and islets. Anat Rec. 1987; 218: 111-115.